FindMyKOL
Clinical trialNCT04567524CompletedPhase 2Interventional

A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules

SponsorLyndra Inc.Enrollment34Schizophrenia Schizoaffective
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Lyndra is developing an oral, extended release (ER) formulation of risperidone (LYN-005) presented in a capsule dosage form with the intent of reducing the frequency of dosing orally-administered medications to once weekly or less and thereby improving the management of schizophrenia. Study LYN-005-C-004 will evaluate the safety, tolerability, and pharmacokinetics (PK) of multiple dose administration of the ER formulation at two dose levels of LYN-005 relative to IR risperidone.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Collaborative Neuroscience Research, Llc

    Long Beach, California, United States

  • Atlanta Center for Medical Research

    Atlanta, Georgia, United States

  • Hassman Research Institute

    Marlton, New Jersey, United States

  • Community Clinical Research, Inc

    Austin, Texas, United States

  • Pillar Clinical Research, Llc

    Richardson, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

LYN-005
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Aug 2020
Primary completion
22 Dec 2020
Completion
22 Dec 2020
Last update posted
8 Feb 2023
Registered enrollment
34
Registry id
NCT04567524

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.